2. vestibular schwannoma (VS) is an encapsulated benign tumour
arising from abnormally proliferative schwann cells.
The commonest nerve of origin is the superior vestibular nerve,
followed by the inferior vestibular and then rarely, the cochlear
nerve
Acoustic neuroma represents 8% of all intracranial tumours and
80% of cerebellopontine angle tumours.
The medial portions of the cranial nerves are covered with glial
stroma. VS originate at the junction of the glial and Schwann cells,
which for the vestibular nerve is usually within the internal
auditory meatus
vestibular schwannoma
3. CEREBELLOPONTINE ANGLE (CPA)
CPA – Irregularly shaped potential space in the posterior fossa of
the brain
Boundary-
Anteriolaterally – Petrous part of temporal bone
Posterior – Cerebellum
Superior – Pons Cerebellar peduncles
Inferior – Cerebellar tonsils
Medial – Lateral surface of the brainstem
4. Content of CPA
CSF
Cranial nerves and their associated vessels
Superior:5th cranial nerve.
7th and 8th nerve
Inferior : 9th,10th,11th nerves
Anterior inferior cerebellar artery
Superior petrosal veins
5. EPIDEMIOLOGY
Both sexes are equally affected
Age presentation is common between the ages of 40 and 60
Majority of these tumours are unilateral, and bilateral (5%) are
seen in neurofibromatosis type 2 (NF2)
Mean growth rate – 1.1 mm /year
6. Tumor pathogenesis
Owing to mutations in the gene for the tumor
suppresor protein MERLIN located on chromosome
22q12
Macroscopically the tumour appears as a firm
yellowish encapsulated mass with the nerve splayed
out on its surface.
Histologically the tumour consists of packed sheaves
of connective tissue cells with intercellular vacuoles
and cysts (reticular pattern). Haemorrhage can occur
(particularly in the reticular type), leading to a sudden
increase in size.
8. TUMOR DEVELOPMENT
Develops in nerve sheath
Compresses rather than invading the nerve
Gradually fills all the IAC & Extrameatal expansion
Tumour extend into cerebellopontine angle
Tumour compress on CN V
tumour compressing on CN V, IX, X, XI
Pressure over brainstem and cerebellum
9. Clinical features
Clinically, two phases can be recognized
Otological phase in which a small tumour compresses structures in
the meatus
Neurological phase as the tumour expands medially into the
cerebellopontine angle.
10. Otological symptoms
Gradual and progressive unilateral deafness is the usual
presenting symptom (90%).
The deafness is often associated with tinnitus (70%). Sudden
onset hearing loss can occur (10%).
Some patients have normal hearing (5%).
Vertigo is an unusual complaint
11. Neurological symptom
5th CN: Earliest sign is impaired corneal reflex. Motor functions are
affected rarely. Facial pain, numbness and paraesthesiae may occur.
7th CN: Sensory first; loss of sensation in the postero-superior aspect
of EAC called (Hitselberger sign).
9th and 1oth CN: hoarseness with dysphagia .palatal, pharyngeal and
laryngeal paralysis.
Late symptom: Ataxia and unsteadiness develop with progressive
brain stem displacement and cerebellar involvement.
13. Radiological investigations.
magnetic resonance imaging (MRI) with gadolinium enhancement is
the gold standard for diagnosis of VC
Medium-sized tumors (3 cm) resemble an ice cream cone on MRI
These tumors enhance intensely with contrast
CT-scan; can not detect intermeatal tumors. but should only be used
when MRI is unavailable
14. Other investigation
Pure tone audiometry - PTA shows assymmetric , down sloping ,
high frequency SNHL in almost 70% of patients
Speech discrimination score (SDS)
Acoustic reflex decay
ABR test- ABR is partially or completely absent , or there is a delay
in latency of wave V on the affected side
Evoked response audiometry (BERA)- It is very useful in the
diagnosis of retrocochlear lesions.
CSF examination
15. Treatment option
Patient’s age and medical condition
Size and the location of the tumor
Auditory and vestibular function of the tumor side and the
contralateral side.
Tumor progression
Surgeon’s preference
17. OBSERVATION
Age >65years, preferred
Patients with vestibular shwannoma in the only hearing ear with
serviceable hearing and no imminent risk to brainstem function.
Tumour growth is monitored .
Serial imaging at 6 months interval is done , if no growth is
seen then yearly
18. STEREOTACTIC RADIATION
A high dose of radiation can be delivered to a defined region,
usually within a well- immobilized system that conforms closely
to the target volume.
Various modalities are:
Gamma knife
LINEAC: Linear Accelerator Photon Radiation Therapy
Proton Beam Therapy